Under the requirement, providers will be reimbursed at least $90 for giving two doses of the Moderna or Pfizer-BioNTech vaccine to members of MassHealth — the name of the state’s Medicaid program — or private health plans. The rate for Johnson & Johnson’s vaccine hasn’t been set yet.
The increase is intended to encourage quick vaccination of the state’s residents, administration officials told the Globe. It’s not a common step other states have taken. Most state Medicaid programs are paying the $45 Medicare rate for the vaccine, Matt Salo, executive director of the National Association of Medicaid Directors, told the newspaper.
While hospitals welcomed the increased reimbursement, Massachusetts insurers expect to spend roughly $400 million on COVID-19 vaccine reimbursement this year, according to the Globe. Those costs will likely be built into insurance premiums.
Read the full report here.
More articles on healthcare finance:
Tennessee hospital abruptly closes
Tennessee hospital loses staff, hasn’t admitted patients since November
15 health systems with strong finances
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
